Clioquinol
- Generic Name
- Clioquinol
- Brand Names
- Locacorten Vioform
- Drug Type
- Small Molecule
- Chemical Formula
- C9H5ClINO
- CAS Number
- 130-26-7
- Unique Ingredient Identifier
- 7BHQ856EJ5
Overview
Clioquinol was withdrawn in 1983 due to neurotoxicity.
Background
Clioquinol was withdrawn in 1983 due to neurotoxicity.
Indication
Used as a topical antifungal treatment.
Associated Conditions
- Acne
- Atopic Dermatitis
- Contact Dermatitis
- Dermatosis
- Eczema impetiginous
- Eczema of the nuchal nape of the neck
- Folliculitis
- Fungal ear infection caused by Aspergillus niger
- Infantile Eczema
- Inflammation
- Intertrigo
- Lichen simplex chronicus
- Moniliasis
- Nummular Dermatitis
- Otitis Externa
- Pruritis of the scroti
- Pruritus Ani
- Pruritus Vulvae
- Pyoderma
- Stasis dermatitis
- Tinea Capitis
- Tinea Corporis
- Tinea Cruris
- Tinea Pedis
- Bacterial skin infections
- Chronic otitis externa
- Corticosteroid-responsive dermatoses
- Disseminated Neurodermatitis
- Localized Neurodermatitis
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
HYDRODERM-C CREAM 1%
Manufacturer:ICM PHARMA PTE. LTD.
Form:CREAM
Strength:3% w/w
Online:Yes
Approved: 1996/07/03
Approval:SIN08790P
DERMANOL-C CREAM 0.1%
Manufacturer:ICM PHARMA PTE. LTD.
Form:CREAM
Strength:3% w/w
Online:Yes
Approved: 1996/07/03
Approval:SIN08795P
DERMANOL-C CREAM 0.05%
Manufacturer:ICM PHARMA PTE. LTD.
Form:CREAM
Strength:3% w/w
Online:Yes
Approved: 1996/07/03
Approval:SIN08796P
DERMANOL-C CREAM 0.025%
Manufacturer:ICM PHARMA PTE. LTD.
Form:CREAM
Strength:3% w/w
Online:Yes
Approved: 1996/07/03
Approval:SIN08793P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath